Table 5

Clinical and healthcare use outcomes of young people with IBD

Chart review resultsTCControl settingEffect size*P value†
No of charts reviewed‡
 T1n=55n=44
 T2n=56n=54
 T3n=30n=24
 T4n=30n=23
Active disease during transfer (yes)§5 (9.1%)18 (34.0%)0.002
Relapse in year before transfer (T2) (yes)§13 (23.6%)27 (50.9%)0.003
Relapse in year after transfer (T3) (yes)¶2 (6.9%)6 (25.0%)0.067
Use of aminosalicylates (yes)
 T122 (40.0%)17 (40.5%)0.962
 T223 (41.1%)21 (38.9%)0.815
 T38 (26.7%)5 (20.8%)0.618
 T49 (30.0%)5 (21.7%)0.499
Use of corticosteroids (yes)
 T117 (30.9%)9 (21.4%)0.296
 T215 (26.8%)14 (25.9%)0.919
 T39 (30.0%)4 (16.7%)0.255
 T410 (33.3%)1 (4.3%)0.010
Use of immunomodulators (yes)
 T140 (72.7%)22 (52.4%)0.039
 T243 (76.8%)31 (57.4%)0.030
 T323 (76.7%)13 (54.2%)0.081
 T425 (83.3%)11 (47.8%)0.006
Use of biologics/biosimilars (yes)
 T14 (7.3%)12 (28.6%)0.005
 T25 (8.9%)20 (37.0%)0.000
 T32 (6.7%)12 (50.0%)0.000
 T43 (10.0%)11 (47.8%)0.002
No of planned consultations per year
 T13.33 (±1.75)3.34 (±2.07)−0.010.972
 T24.71 (±2.08)3.74 (±2.03)0.470.015
 T32.43 (±1.14)2.71 (±1.12)−0.250.378
 T42.23 (±1.50)1.96 (±1.26)0.180.480
No of missed consultations per year
 T10.07 (±0.262)0.07 (±0.334)00.940
 T20.20 (±0.519)0.17 (±0.466)0.060.753
 T30.03 (±0.183)0.13 (±0.338)−0.300.208
 T40.07 (±0.254)0.35 (±0.647)−0.430.034
No of unplanned hospital admissions per year
 T10.30 (±0.836)0.43 (±0.846)−0.150.472
 T20.21 (±0.624)0.41 (±0.858)−0.320.179
 T300.29 (±0.859)−0.330.068
 T40.17 (±0.461)00.370.090
No of emergency department visits per year
 T1 0.24 (±0.838)0.02 (±0.151)0.260.099
 T20.14 (±0.483)0.02 (±0.136)0.250.071
 T30.03 (±0.183)0.25 (±0.847)0.260.178
 T4 00
Department to which young person transferred is recorded/known (yes)55 (98.2%)48 (88.9%)0.045
  • *Cohen’s d (based on largest SD).

  • †Independent samples t-test or Pearson χ2 test.

  • ‡Second year before transfer=T1, year before transfer=T2, year after transfer=T3, second year after transfer=T4.

  • §Control setting n=53, TC setting n=55.

  • ¶TC setting n=29.

  • IBD, inflammatory bowel disease; TC, transition clinic.